サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1345399

血圧計の世界市場-2023年～2030年

Global Sphygmomanometer Market - 2023-2030

出版日
ページ情報
英文 195 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
血圧計の世界市場-2023年～2030年
出版日: 2023年09月06日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

血圧計の世界市場は2022年に28億米ドルに達し、2030年には52億米ドルに達するなど、有利な成長が見込まれています。世界の血圧計市場は予測期間中（2023-2030年）に8.3%のCAGRを示すと予測されています。在宅医療現場での血圧計採用の増加は、市場の主要動向の1つです。

血圧計は、腕に巻き付けるゴム製のカップ、カップを内在させるバルブ、圧力を解放するバルブ、カップの圧力を測定する測定器で構成されます。デジタルまたは電子血圧計は、オシロメトリック測定法を採用しています。操作が簡単で、電池式で自動化されており、水銀を使用していません。

デジタル血圧計には、手動式、自動式、手首式、上腕式、新生児用、小児用の血圧計があります。最も頻繁に使用される血圧計は、手首式と自動式のデジタル血圧計です。

市場力学

血圧計の技術的進歩

血圧計は診断と管理のための血圧測定に不可欠であり、その機能性と技術の進歩に注目したレビューが行われています。ウェアラブル技術、アプリ、モバイルの革新、小売業者や製造業者の平均販売価格の引き下げなど、コンシューマーヘルスケアのカテゴリーにおける技術の進歩が、企業の成長を後押ししています。

Microlife WatchBP home A、QardioArm、LifeSource Sophisticated one-step auto inflate blood pressure monitor、Omron HealthcareのiHealth blood pressure monitorは、市場で最も技術的に洗練されたデジタルBPモニターです。オムロンヘルスケアは、オムロンプラチナやEvolvワイヤレス上腕モニターを含むデジタル血圧モニターの有名なメーカーです。

在宅ケアにおける血圧計の採用増加

ここ数年、遠隔医療の利用が増加しています。COVID-19の大流行が、通常の診療所受診からバーチャルな受診に移行するきっかけとなったにもかかわらず、患者はすぐに遠隔医療にはさらなる利点があることに気づきました。遠隔医療は、以前は医師が求めていた的確で迅速な医療の提案を提供することができます。このように遠隔医療が普及するにつれて、血圧などの健康データを家庭でモニターする必要性が重要になってきました。

在宅ケア環境における血圧計は、患者が自宅で血圧を測定できるようにすることで、利便性、アクセス性、健康アウトカムの改善を提供します。その結果、より頻繁なモニタリング、高血圧コントロールの改善、早期診断と異常の回避、迅速な治療、個人に合わせたケアが可能になります。また、家庭血圧モニタリングは、診療所への受診を減らし、問題や入院を回避するため、費用対効果が高くなります。

市場競争の激化

血圧計市場の成長を妨げる主な要因の1つは、プロバイダー間の強い競争と非正規品の存在です。この業界は、老舗ベンダーだけでなく新規参入の中小企業も複数存在するため、非常に競合が激しくなっています。血圧計の大半は、形状も技術も同等であり、海外ベンダーからも国内ベンダーからも入手可能です。多国籍企業は、利益率を最大化するために、マーケティング、プロモーション、ブランドの品質開拓に多くの投資を行っています。

COVID-19の影響分析

COVID-19は血圧計産業に多くの影響を与えると思われます。なぜなら、高血圧の人はウイルス性疾患を間接的に感染させるため、感染症にかかりやすくなるからです。血圧計は一般的に医療従事者が使用するものであり、人の皮膚を通して感染する可能性のある細菌やバクテリアを含んでいます。その結果、感染のリスクを冒すことなく、自分自身の血圧を検査・監視できるようになれば、市場収益を押し上げることになります。

ロシア・ウクライナ紛争の影響分析

ロシア・ウクライナ紛争は、これまで最大の割合を占めていた慢性非感染性疾患の医療負担を増加させました。アルコール使用や喫煙の増加といった否定的な対処法がこうした健康上の懸念を悪化させ、心血管リスク、特に高血圧を増加させる可能性があり、将来的に血圧計の必要性が高まっています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 血圧計の技術進歩
      • 在宅医療における血圧計の採用の増加
    • 抑制要因
      • 市場における競合の増加
    • 機会
      • 新興市場における成長機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 COVID-19分析

第7章 製品別

  • 電子血圧計
  • アネロイド血圧計
  • 水銀血圧計

第8章 操作別

  • 自動式
  • 半自動式
  • その他

第9章 形状別

  • 携帯型
  • 机上型
  • 床置き型
  • 壁掛け型

第10章 エンドユーザー別

  • 病院
  • 診断検査室
  • 在宅医療

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • OMRON Corporation
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • 3B Scientiifc
  • Acoma Medical Industry Co
  • AmbulanceMed
  • American Diagnostic Corporation
  • Amico Group of Companies
  • A D Company Ltd
  • Bremed Ltd.
  • CIGA Healthcare Ltd
  • HEINE Optotechnik GmbHCo. KG

第14章 付録

目次
Product Code: MD6757

Overview

The global Sphygmomanometer market reached US$ 2.8 billion in 2022 and is estimated to witness lucrative growth by reaching up to US$ 5.2 billion by 2030. The global Sphygmomanometer market is expected to exhibit a CAGR of 8.3% during the forecast period (2023-2030). Increasing adoption of Sphygmomanometers in homecare settings is one of the key trend of the market.

A sphygmomanometer consists of a rubber cup wrapped around the arm, a bulb to innate the cup, a valve to release the pressure, and a measuring instrument to measure the cup's pressure. A digital or electronic sphygmomanometer employs an oscillometric measurement approach. It is simple to operate, battery-powered, automated, and mercury-free.

Digital sphygmomanometers include manual, automatic, wrist, upper arm, neonatal, and paediatric sphygmomanometers. The most often used sphygmomanometers are wrist and automated digital sphygmomanometers.

Market Dynamics

Technological Advancements in Sphygmomanometers

Sphygmomanometers are crucial for assessing blood pressure for diagnosis and management, with reviews focusing on their functionality and advancements in technology. Technological advancements in the consumer healthcare category, such as innovations in wearable technology, apps, and mobiles, as well as reducing average selling prices for retailers and manufacturers, are boosting firm growth.

Microlife WatchBP home A, QardioArm, LifeSource Sophisticated one-step auto inflate blood pressure monitor, and Omron Healthcare's iHealth blood pressure monitor are some of the most technologically sophisticated digital BP monitors on the market. Omron Healthcare is a well-known manufacturer of digital blood pressure monitors, including the Omron Platinum and Evolv Wireless Upper Arm Monitors.

Increasing Adoption of Sphygmomanometers In Homecare Settings

Over the previous few years, telehealth usage has increased. Patients quickly realized that there were additional advantages to telemedicine, despite the fact that the COVID-19 pandemic was the reason for the move from regular clinic visits to virtual ones. Telemedicine can deliver precise and prompt healthcare suggestions that were previously sought by a doctor. With this rising adoption of telehealth, the need for at-home monitoring of health data such as blood pressure has become crucial.

Sphygmomanometers in homecare settings provide convenience, accessibility, and improved health outcomes by allowing patients to test their blood pressure at home. This results in more frequent monitoring, improved hypertension control, early diagnosis and avoidance of anomalies, prompt treatments, and personalised care. Home blood pressure monitoring also decreases clinic visits and avoids problems and hospitalisations, making it cost-effective.

Increasing Competition in the Market

One of the primary factors hindering the growth of the sphygmomanometer market is strong competition among providers, as well as the presence of unauthorised products. The industry has grown extremely competitive as a result of the existence of several new and small firms, as well as well-established vendors. The majority of sphygmomanometers are comparable in form and technology, and they are available from both foreign and local vendors. Multinational firms invest much in marketing, promotion, and brand quality development to maximise their profit margins.

COVID-19 Impact Analysis

COVID-19 will had a numerous impact on the sphygmomanometer industry since people with high blood pressure will be more susceptible to infection owing to the indirect transmission of viral illnesses. Blood pressure monitors are commonly used by healthcare practitioners and contain germs and bacteria that may be transmitted through human skin. As a result, being able to test and monitor one's own blood pressure without risking infection will boost market revenue.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict has increased the healthcare burden for chronic noncommunicable illnesses, which previously accounted for the largest portion. Negative coping techniques, like increased alcohol use and smoking, have exacerbated these health concerns, potentially increasing cardiovascular risks, especially hypertension, and increasing the need for sphygmomanometers in the future.

Segment Analysis

The global sphygmomanometer is segmented based on product, operation, configuration, end user and region.

HomeCare Settings From the End User Segment Accounts for 37.3% of Market Share Owing to Rising Novel Product Launches

The homecare settings from the end user segment with around 37.3% is expected to dominate during the forecast period owing to an increase in the usage of homecare digital sphygmomanometers with sophisticated technology that can communicate patient information wirelessly to clinicians.

For instance, in January 2022, OMRON Healthcare, Inc., a subsidiary of OMRON Corporation, launched Remote Patient Monitoring Services. The service would broaden Digital Health Services to support consumers on each step of their heart health journey. Moreover, this service is created to strengthen the guide behaviour change, patient-physician connection, and reducing risk.

Geographical Analysis

Asia Pacific estimated to hold for Approximately 38.4% of the Market Share

Asia Pacific is estimated to hold about 38.4% of the total market share in the forecasted period, due to the availability of untapped potential, growing hypertension prevalence, and rising awareness levels, is expected to rise substantially over the projected period.

Rapidly improving healthcare facilities, as well as a rise of misdiagnosed patients, are driving regional market expansion. Government efforts to improve public awareness, as well as a rapidly growing target disease population base, are all contributing to the lucrative expansion of this area's BP monitoring devices industry.

For instance, in March 2023, Xiaomi launched the MIJIA electronic blood pressure monitor in China, also known as the MIJIA Electronic Sphygmomanometer. This tie-free device measures blood pressure with just one clamp and stick, eliminating the need for repeated cuff adjustments.

Competitive Landscape

The major global players in the sphygmomanometer include: OMRON Corporation, 3B Scientific, Acoma Medical Industry Co, AmbulanceMed, American Diagnostic Corporation, Amico Group of Companies, A D Company Ltd, Bremed Ltd., CIGA Healthcare Ltd, HEINE Optotechnik GmbHCo. KG and among others.

Why Purchase the Report?

  • To visualize the global sphygmomanometer market segmentation based on product, operation, configuration, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of sphygmomanometer market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global sphygmomanometer report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Operation
  • 3.3. Snippet by Configuration
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological Advancements in Sphygmomanometers
      • 4.1.1.2. Increasing Adoption of Sphygmomanometers In Homecare Settings
    • 4.1.2. Restraints
      • 4.1.2.1. Increasing Competition in the Market
    • 4.1.3. Opportunity
      • 4.1.3.1. Growth Opportunities in Emerging Markets
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post Covid-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Electronic Sphygmomanometer*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Aneroid Sphygmomanometer
  • 7.4. Mercury Sphygmomanometer

8. By Operation

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
    • 8.1.2. Market Attractiveness Index, By Operation
  • 8.2. Automatic *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Semi automatic
  • 8.4. Others

9. By Configuration

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 9.1.2. Market Attractiveness Index, By Configuration
  • 9.2. Portable *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Desk Mounted
  • 9.4. Floor standing
  • 9.5. Wall Mounted

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Diagnostic Laboratories
  • 10.4. Homecare

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Spain
      • 11.3.7.5. Italy
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. OMRON Corporation*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. 3B Scientiifc
  • 13.3. Acoma Medical Industry Co
  • 13.4. AmbulanceMed
  • 13.5. American Diagnostic Corporation
  • 13.6. Amico Group of Companies
  • 13.7. A D Company Ltd
  • 13.8. Bremed Ltd.
  • 13.9. CIGA Healthcare Ltd
  • 13.10. HEINE Optotechnik GmbHCo. KG

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us